Advanced company searchLink opens in new window

ACHILLES THERAPEUTICS UK LIMITED

Company number 10167668

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
02 Mar 2021 CH01 Director's details changed for Dr Iraj Ali on 10 February 2021
19 Feb 2021 PSC05 Change of details for Achilles Tx Limited as a person with significant control on 10 February 2021
10 Feb 2021 SH19 Statement of capital on 10 February 2021
  • GBP 1,234.14398
10 Feb 2021 SH20 Statement by Directors
10 Feb 2021 CAP-SS Solvency Statement dated 04/02/21
10 Feb 2021 RESOLUTIONS Resolutions
  • RES13 ‐ Cancel share prem reserve 08/02/2021
04 Feb 2021 PSC07 Cessation of Syncona Limited as a person with significant control on 11 December 2020
04 Feb 2021 PSC02 Notification of Achilles Tx Limited as a person with significant control on 11 December 2020
02 Feb 2021 PSC05 Change of details for Syncona Limited as a person with significant control on 18 November 2020
01 Feb 2021 PSC05 Change of details for Syncona Limited as a person with significant control on 1 October 2020
18 Jan 2021 SH10 Particulars of variation of rights attached to shares
14 Jan 2021 RESOLUTIONS Resolutions
  • RES13 ‐ Change of company name/share plans/company documents 11/01/2021
  • RES01 ‐ Resolution of adoption of Articles of Association
14 Jan 2021 MA Memorandum and Articles of Association
13 Jan 2021 RESOLUTIONS Resolutions
  • NM01 ‐ Change of name by resolution
  • RES15 ‐ Change company name resolution on 2021-01-11
12 Jan 2021 AD01 Registered office address changed from Stevenage Bioscience Catalyst Gunnels Wood Road Stevenage SG1 2FX England to 245 Hammersmith Road London W6 8PW on 12 January 2021
12 Jan 2021 TM01 Termination of appointment of Carsten Boess as a director on 11 January 2021
12 Jan 2021 TM01 Termination of appointment of Michael Francis Giordano as a director on 11 January 2021
12 Jan 2021 TM01 Termination of appointment of Derek Dirocco as a director on 11 January 2021
12 Jan 2021 TM01 Termination of appointment of Martin Murphy as a director on 11 January 2021
12 Jan 2021 TM01 Termination of appointment of Edwin Moses as a director on 11 January 2021
12 Jan 2021 AP01 Appointment of Robert William Coutts as a director on 11 January 2021
12 Jan 2021 TM01 Termination of appointment of Rogier Wouter Rooswinkel as a director on 11 January 2021
12 Jan 2021 TM01 Termination of appointment of Karl Peggs as a director on 22 December 2020
08 Jan 2021 SH06 Cancellation of shares. Statement of capital on 11 December 2020
  • GBP 1,234.14398
08 Jan 2021 SH03 Purchase of own shares.